Alabama Administrative Code
Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS
Chapter 540-X-26 - COLLABORATIVE PHARMACY PRACTICE
Section 540-X-26-.05 - Limitations
Universal Citation: AL Admin Code R 540-X-26-.05
Current through Register Vol. 42, No. 11, August 30, 2024
(1) The scope of an Agreement shall NOT include:
(a) Any person or
patient of a Collaborating Physician for whom such Collaborating Physician has
not prepared a patient-specific, drug- or drug class-specific,
disease-specific, or condition-specific plan of care based on a physical
examination of the patient by the Collaborating Physician within the past
twelve (12) months, with the exception of immunizations and acute,
uncomplicated illness or injury as well as the dispensing of opioid antagonists
as defined in Ala. Code §
20-2-280; or
(b) The prescribing of controlled substances
listed or to be listed in the schedules under federal law and in Ala. Code
§§
20-2-23,
20-2-25,
20-2-27,
20-2-29, and
20-2-31 and/or Ala. Admin. Code r.
420-7-2 and its Appendix.
(2) No retail pharmacy may employ a physician for the purpose of maintaining, establishing, or entering into a collaborative practice agreement. Nothing shall prohibit a retail pharmacy from hiring a physician or licensed medical practitioner for the purpose of conducting quality assurance reviews of its pharmacists that are engaged in the practice of collaborative drug therapy.
Author: Alabama Board of Medical Examiners
Statutory Authority: Code of Ala. 1975, § 34-24-53; Act 2019-368 (Code of Ala. 1975, § 34-23-77).
Disclaimer: These regulations may not be the most recent version. Alabama may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
